Supplemental Figure S1
Cell viability measurements in AML cells pretretead for 6 hours and treated for 24 hrs with midostaurin (PKC412) and NVP-HDM201 in all combinations. NVP-HDM201 pretreatment followed by midostaurin treatment had the same effect on cell viability as midostaurin pretreatment followed by NVP-HDM201 treatment. Moreover both sequential treatments had nearly the same effect on cell viability as 30hrs of direct combination treatment in OCI-AML2 cells (A) and MOLM-13 cells (B). 
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